208 related articles for article (PubMed ID: 7852525)
21. Follicle-stimulating hormone-secreting pituitary adenoma manifesting as recurrent ovarian cysts in a young woman--latent risk of unidentified ovarian hyperstimulation: a case report.
Kawaguchi T; Ogawa Y; Ito K; Watanabe M; Tominaga T
BMC Res Notes; 2013 Oct; 6():408. PubMed ID: 24119690
[TBL] [Abstract][Full Text] [Related]
22. Recognition of gonadotroph adenomas in women.
Daneshdoost L; Gennarelli TA; Bashey HM; Savino PJ; Sergott RC; Bosley TM; Snyder PJ
N Engl J Med; 1991 Feb; 324(9):589-94. PubMed ID: 1899470
[TBL] [Abstract][Full Text] [Related]
23. Ovarian hyperstimulation syndrome due to follicle-stimulating hormone-secreting pituitary adenomas.
Caretto A; Lanzi R; Piani C; Molgora M; Mortini P; Losa M
Pituitary; 2017 Oct; 20(5):553-560. PubMed ID: 28676954
[TBL] [Abstract][Full Text] [Related]
24. Gonadotroph cell pituitary adenomas.
Snyder PJ
Endocrinol Metab Clin North Am; 1987 Sep; 16(3):755-64. PubMed ID: 3319601
[TBL] [Abstract][Full Text] [Related]
25. Spontaneous ovarian hyperstimulation syndrome caused by a follicle-stimulating hormone-secreting pituitary macroadenoma in an early pubertal girl.
Gryngarten MG; Braslavsky D; Ballerini MG; Ledesma J; Ropelato MG; Escobar ME
Horm Res Paediatr; 2010; 73(4):293-8. PubMed ID: 20215777
[TBL] [Abstract][Full Text] [Related]
26. Spontaneous ovarian hyperstimulation caused by a follicle-stimulating hormone-secreting pituitary adenoma.
Roberts JE; Spandorfer S; Fasouliotis SJ; Lin K; Rosenwaks Z
Fertil Steril; 2005 Jan; 83(1):208-10. PubMed ID: 15652911
[TBL] [Abstract][Full Text] [Related]
27. A spontaneous and severe hyperstimulation of the ovaries revealing a gonadotroph adenoma.
Christin-Maitre S; Rongières-Bertrand C; Kottler ML; Lahlou N; Frydman R; Touraine P; Bouchard P
J Clin Endocrinol Metab; 1998 Oct; 83(10):3450-3. PubMed ID: 9768644
[TBL] [Abstract][Full Text] [Related]
28. Structure-function correlations of human pituitary gonadotroph adenomas in vitro.
Asa SL; Gerrie BM; Kovacs K; Horvath E; Singer W; Killinger DW; Smyth HS
Lab Invest; 1988 Apr; 58(4):403-10. PubMed ID: 2451766
[TBL] [Abstract][Full Text] [Related]
29. Gonadotroph Pituitary Adenoma Causing Treatable Infertility and Ovarian Hyperstimulation Syndrome in Female Patients: Neurosurgical, Endocrinologic, Gynecologic, and Reproductive Outcomes.
Hasegawa H; Nesvick CL; Erickson D; Cohen SC; Yolcu YU; Khan Z; Raghunathan A; Nippoldt TB; Atkinson JL; Van Gompel JJ
World Neurosurg; 2021 Jun; 150():e162-e175. PubMed ID: 33684575
[TBL] [Abstract][Full Text] [Related]
30. Exacerbation of ovarian hyperstimulation by leuprolide reveals a gonadotroph adenoma.
Castelbaum AJ; Bigdeli H; Post KD; Freedman MF; Snyder PJ
Fertil Steril; 2002 Dec; 78(6):1311-3. PubMed ID: 12477530
[TBL] [Abstract][Full Text] [Related]
31. An immunohistochemical and ultrastructural study of a follicle-stimulating hormone-secreting gonadotroph adenoma occurring in a 10-year-old girl.
Tashiro H; Katabuchi H; Ohtake H; Yoshioka A; Matsumura S; Suenaga Y; Nagamura Y; Matsuura K; Okamura H
Med Electron Microsc; 2000; 33(1):25-31. PubMed ID: 11810454
[TBL] [Abstract][Full Text] [Related]
32. Responses to gonadotropin releasing hormone agonist and antagonist administration in patients with gonadotroph cell adenomas.
Chanson P; Lahlou N; Warnet A; Roger M; Sassolas G; Lubetzi J; Schaison G; Bouchard P
J Endocrinol Invest; 1994 Feb; 17(2):91-8. PubMed ID: 8006338
[TBL] [Abstract][Full Text] [Related]
33. Spontaneous ovarian hyperstimulation syndrome and pituitary adenoma: incidental pregnancy triggers a catastrophic event.
Baba T; Endo T; Kitajima Y; Kamiya H; Moriwaka O; Saito T
Fertil Steril; 2009 Jul; 92(1):390.e1-3. PubMed ID: 19356755
[TBL] [Abstract][Full Text] [Related]
34. Follicle-stimulating hormone-secreting pituitary adenomas: correlation of reduction of adenoma size with reduction of hormonal hypersecretion after transsphenoidal surgery.
Harris RI; Schatz NJ; Gennarelli T; Savino PJ; Cobbs WH; Snyder PJ
J Clin Endocrinol Metab; 1983 Jun; 56(6):1288-93. PubMed ID: 6404924
[TBL] [Abstract][Full Text] [Related]
35. Gonadotropin-releasing hormone agonists are unsuccessful in reducing tumoral gonadotropin secretion in two patients with gonadotropin-secreting pituitary adenomas.
Sassolas G; Lejeune H; Trouillas J; Forest MG; Claustrat B; Lahlou N; Loras B
J Clin Endocrinol Metab; 1988 Jul; 67(1):180-5. PubMed ID: 2967850
[TBL] [Abstract][Full Text] [Related]
36. Functioning gonadotroph adenoma with severe ovarian hyperstimulation syndrome: A new emergency in pituitary adenoma surgery? Surgical considerations and literature review.
Graillon T; Castinetti F; Chabert-Orsini V; Morange I; Cuny T; Albarel F; Brue T; Dufour H
Ann Endocrinol (Paris); 2019 Apr; 80(2):122-127. PubMed ID: 30825998
[TBL] [Abstract][Full Text] [Related]
37. Abnormal response of luteinizing hormone beta subunit to thyrotrophin-releasing hormone in patients with non-functioning pituitary adenoma.
Gil-del-Alamo P; Pettersson KS; Saccomanno K; Spada A; Faglia G; Beck-Peccoz P
Clin Endocrinol (Oxf); 1994 Nov; 41(5):661-6. PubMed ID: 7828356
[TBL] [Abstract][Full Text] [Related]
38. Usefulness of thyrotropin-releasing hormone test, SMS 201-995, and bromocriptine in the diagnosis and treatment of gonadotropin-secreting pituitary adenomas.
Blanco C; Lucas T; Alcañiz J; Davila N; Serrano P; Barcelò B; Estrada J
J Endocrinol Invest; 1994 Feb; 17(2):99-104. PubMed ID: 8006339
[TBL] [Abstract][Full Text] [Related]
39. A clinically functioning gonadotroph adenoma presenting with abdominal pain, ovarian hyperstimulation and fibromatosis.
Broughton C; Mears J; Williams A; Lonnen K
Endocrinol Diabetes Metab Case Rep; 2018; 2018():. PubMed ID: 30532999
[TBL] [Abstract][Full Text] [Related]
40. Reduction of follicle-stimulating hormone (FSH) secretion in FSH-producing pituitary adenoma by bromocriptine.
Berezin M; Olchovsky D; Pines A; Tadmor R; Lunenfeld B
J Clin Endocrinol Metab; 1984 Dec; 59(6):1220-3. PubMed ID: 6436289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
